Why Veeva Systems (VEEV) is a Top Momentum Stock for the Long-Term

Veeva Systems (VEEV) is highlighted as a top momentum stock, currently holding a Zacks Rank #1 (Strong Buy) and a VGM Score of B. Shares are up 20.1% in the last four weeks, with a Momentum Style Score of A, and fiscal year 2026 earnings estimates have been revised upwards by 10 analysts in the last 60 days, increasing the consensus to $7.56 per share.

Analysis

Veeva Systems (VEEV) exhibits a compelling investment profile, highlighted by its Zacks Rank #1 (Strong Buy) and a VGM Score of B, indicating strong overall fundamentals. The company's Momentum Style Score of A is substantiated by a significant 20.1% increase in its share price over the past four weeks. This positive momentum is further reinforced by favorable analyst actions, with 10 analysts revising their fiscal 2026 earnings estimates upwards in the last 60 days. Consequently, the Zacks Consensus Estimate for fiscal 2026 earnings per share has risen by $0.25 to $7.56. Veeva Systems, a provider of cloud-based software applications and data solutions for the life sciences industry, also demonstrates a consistent ability to outperform expectations, evidenced by an average earnings surprise of 10%. The confluence of these factors—top-tier ranking, robust style scores, strong recent stock performance, and positive earnings estimate revisions—positions VEEV as a noteworthy stock, particularly for investors seeking exposure to momentum within the medical technology sector.

Key Decisions for Investors

• Investors may consider Veeva Systems as a candidate for growth and momentum-oriented portfolios, given its #1 Zacks Rank, 'A' Momentum Score, and positive earnings estimate revisions.
• Monitoring ongoing analyst earnings estimate revisions for fiscal 2026 and the persistence of share price momentum is advised to assess the sustainability of the current positive outlook.
• Considering the recent 20.1% appreciation in share price, investors might evaluate strategic entry points or consider a phased investment approach to manage potential valuation sensitivity while capitalizing on the established upward trend.